CI-1033

· Pfizer

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CI-1033, covering 2006-11-08 to 2007-05-04. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer [Phase 2]